Literature DB >> 22573325

Matrix metalloprotease-1a promotes tumorigenesis and metastasis.

Caitlin J Foley1, Chi Luo, Katie O'Callaghan, Philip W Hinds, Lidija Covic, Athan Kuliopulos.   

Abstract

Matrix metalloprotease-1 (MMP1), a collagenase and activator of the G protein-coupled protease activated receptor-1 (PAR1), is an emerging new target implicated in oncogenesis and metastasis in diverse cancers. However, the functional mouse homologue of MMP1 in cancer models has not yet been clearly defined. We report here that Mmp1a is a functional MMP1 homologue that promotes invasion and metastatic progression of mouse lung cancer and melanoma. LLC1 (Lewis lung carcinoma) and primary mouse melanoma cells harboring active BRAF express high levels of endogenous Mmp1a, which is required for invasion through collagen. Silencing of either Mmp1a or PAR1 suppressed invasive stellate growth of lung cancer cells in three-dimensional matrices. Conversely, ectopic expression of Mmp1a conferred an invasive phenotype in epithelial cells that do not express endogenous Mmp1a. Consistent with Mmp1a acting as a PAR1 agonist in an autocrine loop, inhibition or silencing of PAR1 resulted in a loss of the Mmp1a-driven invasive phenotype. Knockdown of Mmp1a on tumor cells resulted in significantly decreased tumorigenesis, invasion, and metastasis in xenograft models. Together, these data demonstrate that cancer cell-derived Mmp1a acts as a robust functional homologue of MMP1 by conferring protumorigenic and metastatic behavior to cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573325      PMCID: PMC3397859          DOI: 10.1074/jbc.M112.356303

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice.

Authors:  Bettina Hartenstein; Bernd Thilo Dittrich; Dominique Stickens; Babette Heyer; Thiennu H Vu; Sibylle Teurich; Marina Schorpp-Kistner; Zena Werb; Peter Angel
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

2.  Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth.

Authors:  Colby A Wyatt; James C Geoghegan; Constance E Brinckerhoff
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 3.  Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

Authors:  Miriam Fanjul-Fernández; Alicia R Folgueras; Sandra Cabrera; Carlos López-Otín
Journal:  Biochim Biophys Acta       Date:  2009-07-23

4.  Metalloproteases and the degradome.

Authors:  Alejandro P Ugalde; Gonzalo R Ordóñez; Pedro M Quirós; Xose S Puente; Carlos López-Otín
Journal:  Methods Mol Biol       Date:  2010

5.  Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Sonam A Shah; Francis G Spinale; John S Ikonomidis; Robert E Stroud; Eileen I Chang; Carolyn E Reed
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04       Impact factor: 5.209

6.  Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.

Authors:  Eric Yang; Adrienne Boire; Anika Agarwal; Nga Nguyen; Katie O'Callaghan; Powen Tu; Athan Kuliopulos; Lidija Covic
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

7.  Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells.

Authors:  Nga Nguyen; Athan Kuliopulos; Roger A Graham; Lidija Covic
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

8.  Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3.

Authors:  Stefanie Pfaffen; Teresa Hemmerle; Marcel Weber; Dario Neri
Journal:  Exp Cell Res       Date:  2009-11-12       Impact factor: 3.905

Review 9.  Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics.

Authors:  David Rodríguez; Charlotte J Morrison; Christopher M Overall
Journal:  Biochim Biophys Acta       Date:  2009-10-01

10.  A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Authors:  J S Blackburn; I Liu; C I Coon; C E Brinckerhoff
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more
  28 in total

1.  MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.

Authors:  Peter C Lucas; Linda M McAllister-Lucas; J Randall McAuley; Kelly M Bailey; Prasanna Ekambaram; Linda R Klei; Heejae Kang; Dong Hu; Tanner J Freeman; Vincent J Concel; Nathaniel E Hubel; Jia-Ying Lloyd Lee; Hanna B Klei; Jing Cheng; Preethiya Sekar; Rachel E Bridwell; Lidija Covic
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

2.  Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.

Authors:  Rajashree Rana; Tianfang Huang; Georgios Koukos; Elizabeth K Fletcher; Susan E Turner; Andrew Shearer; Paul A Gurbel; Jeffrey J Rade; Carey D Kimmelstiel; Kevin P Bliden; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04-05       Impact factor: 8.311

3.  Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.

Authors:  Chi Luo; Jinghao Sheng; Miaofen G Hu; Frank G Haluska; Rutao Cui; Zhengping Xu; Philip N Tsichlis; Guo-Fu Hu; Philip W Hinds
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

Review 4.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

5.  A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.

Authors:  Chi Luo; Ji-Hong Lim; Yoonjin Lee; Scott R Granter; Ajith Thomas; Francisca Vazquez; Hans R Widlund; Pere Puigserver
Journal:  Nature       Date:  2016-08-31       Impact factor: 49.962

Review 6.  [Novel achievements in development and application of GPCR-peptides].

Authors:  A O Shpakov; K V Derkach
Journal:  Zh Evol Biokhim Fiziol       Date:  2015 Jan-Feb

7.  Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.

Authors:  Miriam Fanjul-Fernández; Alicia R Folgueras; Antonio Fueyo; Milagros Balbín; María F Suárez; M Soledad Fernández-García; Steven D Shapiro; José M P Freije; Carlos López-Otín
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

8.  Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

Authors:  C J Foley; M Fanjul-Fernández; A Bohm; N Nguyen; A Agarwal; K Austin; G Koukos; L Covic; C López-Otín; A Kuliopulos
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

9.  Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination.

Authors:  Anna Juncker-Jensen; Elena I Deryugina; Ivo Rimann; Ewa Zajac; Tatyana A Kupriyanova; Lars H Engelholm; James P Quigley
Journal:  Cancer Res       Date:  2013-05-16       Impact factor: 12.701

Review 10.  Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.

Authors:  Aaron Dolor; Francis C Szoka
Journal:  Mol Pharm       Date:  2018-05-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.